Gilead Sciences, Inc. (GILD) Stock Overview
Explore Gilead Sciences, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Gilead Sciences, Inc. (GILD)
Key Financials
Key Financials
Market Cap
161.8B
P/E Ratio
17.95
EPS (TTM)
$8.37
ROE
0.42%
GILD Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Gilead Sciences, Inc. (GILD) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 49.48, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $160.11.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 17.95 and a market capitalization of 161.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.